Table 1.
Comparison between both groups at baseline
| Azithromycin group (n = 13) (mean ± SD) |
NB-UVB (n = 11) (mean ± SD) |
p value | |
|---|---|---|---|
| Age (years) | 12 ± 5.29 | 18.73 ± 19.02 | 0.279 |
| Sex |
Females 8 (72.7%) Males 5 (38.5%) |
Females 3 (27.3%) Males 8 (61.5%) |
0.102 |
| Duration (months) | 27.46 ± 22.99 | 25.18 ± 19.49 | 0.795 |
| Extent of the rash as a whole (% body surface) | 18.56 ± 13.94 | 12.27 ± 5.27 | 0.152 |
| Extent of the erythematous papules (% body surface) | |||
| Face | 0.31 ± 0.59 | 0.16 ± 0.32 | 0.443 |
| Trunk (front) | 2.13 ± 2.41 | 1.23 ± 1.21 | 0.248 |
| Trunk (back) | 1.85 ± 2.47 | 1.27 ± 1.12 | 0.463 |
| Upper extremities | 3.13 ± 4.80 | 1.93 ± 1.78 | 0.352 |
| Lower extremities | 3.75 ± 4.33 | 2.05 ± 1.27 | 0.198 |
| Total extension | 11.9 ± 13.54 | 6.68 ± 3.96 | 0.271 |
| Extent of the hypopigmented lesions (% body surface) | |||
| Face | 0.35 ± 0.42 | 0.27 ± 0.39 | 0.662 |
| Trunk (front) | 1.63 ± 2.67 | 1.18 ± 1.03 | 0.581 |
| Trunk (back) | 1.48 ± 2.62 | 1.05 ± 1.01 | 0.589 |
| Upper extremities | 1.75 ± 2.05 | 1 ± 0.74 | 0.238 |
| Lower extremities | 2 ± 2.04 | 2.09 ± 1.87 | 0.91 |
| Total extension | 7.37 ± 9.33 | 5.59 ± 3.91 | 0.541 |
*p value < 0.05 is significant